Literature DB >> 9207053

Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.

B S Blumberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9207053      PMCID： PMC33676          DOI： 10.1073/pnas.94.14.7121

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  3 in total

Review 1.  Australia antigen and the biology of hepatitis B.

Authors:  B S Blumberg
Journal:  Science       Date:  1977-07-01       Impact factor: 47.728

Review 2.  Viral hepatitis and hepatocellular carcinoma.

Authors:  R Sallie; A M Di Bisceglie
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

3.  Complex interactions of hepatitis B virus with its host and environment. The Croonian Lecture 1994.

Authors:  B S Blumberg
Journal:  J R Coll Physicians Lond       Date:  1995 Jan-Feb
  3 in total
  36 in total

1.  The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; David M Belnap; Alasdair C Steven; Paul T Wingfield
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Diversity of core antigen epitopes of hepatitis B virus.

Authors:  D M Belnap; N R Watts; J F Conway; N Cheng; S J Stahl; P T Wingfield; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

3.  Stability and shape of hepatitis B virus capsids in vacuo.

Authors:  Charlotte Uetrecht; Cees Versluis; Norman R Watts; Paul T Wingfield; Alasdair C Steven; Albert J R Heck
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

4.  A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.

Authors:  Mei Liu; Xinxin Liu; Pengfei Ren; Jitian Li; Yurong Chai; Su-Jun Zheng; Yu Chen; Zhong-Ping Duan; Ning Li; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-01-04

5.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

6.  Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.

Authors:  S Ren; M Nassal
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.

Authors:  Pong Kian Chua; Fan-Mei Tang; Jyuan-Yuan Huang; Ching-Shu Suen; Chiaho Shih
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 8.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

9.  Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation.

Authors:  M Koschel; R Thomssen; V Bruss
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Nuclear export and import of human hepatitis B virus capsid protein and particles.

Authors:  Hung-Cheng Li; Er-Yi Huang; Pei-Yi Su; Szu-Yao Wu; Ching-Chun Yang; Young-Sun Lin; Wen-Chang Chang; Chiaho Shih
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.